SastiMedic
Fludocyte 50mg Injection

Fludocyte 50mg Injection

MRP: ₹10,277.00

Packaging

INJECTION

Composition

Fludarabine 50mg

Company

Intas

Buy Now

Substitutes for Fludocyte 50mg Injection

Medicine Company Price You Save
Fludaphos 50mg Injection Bharat Serum & Vaccines ₹5,557.00 Save ₹4,720.00
Fludacel 50mg Injection Celon Labs ₹6,500.00 Save ₹3,777.00
Naprobin 50mg Injection Miracauls ₹7,500.00 Save ₹2,777.00
Fludabine 50mg Inj. United Biotech ₹10,500.00

Side Effects of Fludocyte 50mg Injection

Fever, chills, cough, dyspnoea, pneumonia; GI disturbances, stomatitis; oedema; tumour lysis syndrome; skin rashes; haemolytic anaemia, haemorrhagic cystitis; neurological disturbances including peripheral neuropathy, agitation, confusion, visual disturbances and coma. Progressive encephalopathy and blindness (high doses). Potentially Fatal: Myelosuppression. Fatal autoimmune haemolytic anemia.

Drug Interactions

Co-administration with pentostatin may lead to pulmonary toxicity. Reduced metabolic activation of fludarabine with cytarabine. Reduced therapeutic efficacy with dipyridamole and other adenosine uptake inhibitors.

Contraindications

Renal impairment (CrCl <30 mL/min); decompensated haemolytic anaemia. Pregnancy and lactation. Concomitant use of live vaccines.

Mechanism of Action

Fludarabine is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP which inhibits DNA polymerase and ribonucleotide reductase resulting in inhibition of DNA synthesis leading to cell death. Metabolism: IV: Fludarabine phosphate is rapidly dephosphorylated in the serum to fludarabine which enters the tumor cells to be rephosphorylated to the active triphosphate derivative. Excretion: Mostly in the urine, about 60% of dose is excreted within 24 hr.

Special Precautions

Routine monitoring of blood counts and Hb conc. Monitor for signs of autoimmune haemolytic anaemia; elderly. Avoid contact with skin and eyes; avoid inhalation. Myelosuppression may be cumulative and severe increasing risk of opportunistic infections. Increased risk of tumour lysis syndrome in patients with high tumour burden.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

  • Alcohol: Avoid during treatment.
  • Breastfeeding: Not recommended.
  • Pregnancy: Contraindicated.
  • Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.

More brands by Intas

Written by: SastiMedic Medical Team

Reviewed by: Registered Pharmacist